SOURCE: Marathon Patent Group

June 03, 2015 09:05 ET

Marathon Patent Group's Subsidiary, Selene Communication Technologies, LLC, Enters Into Settlement and License Agreement With Thomson Reuters Inc.

LOS ANGELES, CA--(Marketwired - Jun 3, 2015) - Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"), a patent licensing company, announced today that on May 26, 2015, the company's subsidiary Selene Communication Technologies, LLC, ("Selene") entered into settlement and license agreement with Thomson Reuters Inc. The consideration to be paid by Thomson Reuters Inc. to Selene and all other terms of the license agreement are confidential.

Selene's U.S. patent assets include U.S. Patent Nos. 7,143,444 and 6,363,377.

The '377 Patent is currently being asserted against Reed Elsevier Inc. in the United States District Court for the District of Delaware. The '444 Patent is currently being asserted against Fluke Electronics Corporation in the United States District Court for the District of Delaware and Trend Micro Inc., in the United States District Court for the Northern District of California. Mishcon de Reya New York LLP is representing Selene in these actions.

About Marathon Patent Group:

Marathon is a patent acquisition and monetization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. To learn more about Marathon Patent Group, visit www.marathonpg.com.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contact Information